(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.47%) $83.46
(-1.16%) $1.619
(-0.06%) $2 345.90
(0.74%) $27.46
(0.28%) $924.70
(-0.06%) $0.934
(-0.13%) $11.01
(-0.05%) $0.800
(0.00%) $92.17
0.00% $ 28.24
Live Chart Being Loaded With Signals
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses...
Stats | |
---|---|
Dzisiejszy wolumen | 0.00 |
Średni wolumen | 438 704 |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.850 ( 2022-05-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.54 |
ATR14 | $0.137 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-13 | Meier Richard A | Sell | 57 230 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 65 759 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 40 607 | Common Stock |
2022-05-13 | Meier Richard A | Sell | 34 000 | Stock Options (Right to buy) |
2022-05-13 | Meier Richard A | Sell | 74 852 | Stock Options (Right to buy) |
INSIDER POWER |
---|
-100.00 |
Last 98 transactions |
Buy: 482 629 | Sell: 874 745 |
Wolumen Korelacja
Intersect Ent Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
GLLI | 0.937 |
ACAB | 0.933 |
FEXD | 0.929 |
APMI | 0.929 |
FNVT | 0.929 |
AVAC | 0.928 |
CBRG | 0.926 |
CIIG | 0.925 |
BRIV | 0.923 |
ALSA | 0.921 |
10 Najbardziej negatywne korelacje | |
---|---|
EVLO | -0.925 |
NCBS | -0.923 |
IRBT | -0.922 |
CREG | -0.92 |
DRUG | -0.917 |
ATAI | -0.916 |
CRON | -0.913 |
ARQQ | -0.912 |
BLU | -0.911 |
VFF | -0.91 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Intersect Ent Inc Korelacja - Waluta/Towar
Intersect Ent Inc Finanse
Annual | 2021 |
Przychody: | $106.75M |
Zysk brutto: | $76.74M (71.89 %) |
EPS: | $-4.80 |
FY | 2021 |
Przychody: | $106.75M |
Zysk brutto: | $76.74M (71.89 %) |
EPS: | $-4.80 |
FY | 2020 |
Przychody: | $80.55M |
Zysk brutto: | $50.25M (62.38 %) |
EPS: | $-2.22 |
FY | 2019 |
Przychody: | $109.14M |
Zysk brutto: | $87.37M (80.05 %) |
EPS: | $-1.370 |
Financial Reports:
No articles found.
Intersect Ent Inc
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej